Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.

Abd-Elaziz K, Oude Elberink H, Diamant Z

Open source

DOI
10.1080/20018525.2020.1809083
Published
2020 Aug 20
Container
European clinical respiratory journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20018525.2020.1809083,
  title = {Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.},
  author = {Abd-Elaziz K and Oude Elberink H and Diamant Z},
  year = {2020},
  journal = {European clinical respiratory journal},
  doi = {10.1080/20018525.2020.1809083},
  url = {https://doi.org/10.1080/20018525.2020.1809083}
}

RIS

TY  - JOUR
TI  - Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.
AU  - Abd-Elaziz K
AU  - Oude Elberink H
AU  - Diamant Z
PY  - 2020
JO  - European clinical respiratory journal
DO  - 10.1080/20018525.2020.1809083
UR  - https://doi.org/10.1080/20018525.2020.1809083
ER  - 

APA

K, A., H, O. E., & Z, D. (2020). Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.. European clinical respiratory journal. https://doi.org/10.1080/20018525.2020.1809083

Source records